Publication date: December 2026 Source: ESMO Gastrointestinal Oncology, Volume 14 Author(s): Y. Tong, I. Nakayama, N. Sakamoto, Y. Miyashita, Y. Shiba, U. Hirotaka, Y. Sugawara, D. Okemoto, K. Yamamoto, K. Seguchi, T. Ogura, Y. Matsubara, T. Hashimoto, S. Mishima, D. Kotani, A. Kawazoe, Y. Kuboki, H. Bando, T. Kojima, T. Yoshino
TROP2 expression in gastric and GEJ adenocarcinomas: associations with clinicopathological features, biomarkers, and treatment outcomes. // ESMO Gastrointestinal Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949819826001135?dgcid=rss_sd_all
TROP2 expression in gastric and GEJ adenocarcinomas: associations with clinicopathological features, biomarkers, and treatment outcomes. ESMO Gastrointestinal Oncology. https://www.sciencedirect.com/science/article/pii/S2949819826001135?dgcid=rss_sd_all
“TROP2 expression in gastric and GEJ adenocarcinomas: associations with clinicopathological features, biomarkers, and treatment outcomes.” ESMO Gastrointestinal Oncology.
@article{article44691,
title = {TROP2 expression in gastric and GEJ adenocarcinomas: associations with clinicopathological features, biomarkers, and treatment outcomes},
journal = {ESMO Gastrointestinal Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949819826001135?dgcid=rss_sd_all}
}